NASOPHARYNGEAL CANCINOMA (NPC)
Clinical trials for NASOPHARYNGEAL CANCINOMA (NPC) explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CANCINOMA (NPC) trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CANCINOMA (NPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extra pill after chemoradiation could boost fight against nasopharyngeal cancer
Disease control OngoingThis study is for people with a specific, high-risk type of nasopharyngeal cancer. All participants get the standard treatment of chemotherapy and radiation together. For those whose blood tests still show signs of the cancer virus during treatment, the study tests if adding a lo…
Matched conditions: NASOPHARYNGEAL CANCINOMA (NPC)
Phase: PHASE3 • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Personalized radiation strategy tested for advanced throat cancer
Disease control OngoingThis study is testing whether adding a drug called tislelizumab to standard chemotherapy, followed by a personalized radiation plan, can better control advanced nasopharyngeal cancer that has already spread. It enrolled 32 adults whose tumors shrank after initial chemo-immunother…
Matched conditions: NASOPHARYNGEAL CANCINOMA (NPC)
Phase: NA • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC